PT-2 Octreotide

About Imagine Pharma

Imagine Pharma is a private, pre-clinical stage biotech leveraging a novel polypeptide (IMG-1) to build three distinct therapeutic platforms: Oral Delivery of biologics, novel Therapeutics, and Regenerative Medicine. Its pipeline includes early-stage programs for oral EPO, skin grafts, diabetic wounds, and autologous islet transplants for Type 1 Diabetes. The company appears to be pre-revenue, focusing on R&D and seeking partnerships to advance its broad portfolio of platform-derived programs.

Therapeutic Areas